DXCM vs. PEN: DexCom vs. Penumbra Stock Comparison
How do DexCom (DXCM) and Penumbra (PEN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DexCom (DXCM) and Penumbra (PEN) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | DXCM | PEN |
|---|---|---|
| Name | DexCom Inc. | Penumbra Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 29.62 billion USD | 12.58 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | April 14, 2005 | September 18, 2015 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DXCM | PEN |
|---|---|---|
| Total Return (1Y) | 46.33% | 20.52% |
| Total Return (3Y, Annualized) | -4.50% | 20.38% |
| Total Return (5Y, Annualized) | -12.76% | 3.15% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
DexCom (DXCM) has an aggressive beta of 1.43, indicating higher sensitivity to broad-market moves, while Penumbra (PEN) is defensive at 0.68 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | DXCM | PEN |
|---|---|---|
| Volatility (1Y, Annualized) | 38.37% | 19.78% |
| Beta (5Y) | 1.43 | 0.68 |
| Max Drawdown (5Y) | -66.32% | -59.60% |
| Avg. Volume (3M) | 4.34M | 348.64K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DXCM | PEN |
|---|---|---|
| Sharpe Ratio (1Y) | 1.10 | 0.82 |
| Sortino Ratio (1Y) | 1.79 | 1.56 |
Profitability
ROE (TTM)
DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Penumbra (PEN) at 10.67% is closer to the peer norm — stronger capital efficiency for DXCM.
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
PEN
Health Care Equipment & Services industry group
10.67%
- Max
- 47.61%
- Q3
- 14.36%
- PEN
- 10.67%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both DexCom (DXCM) at 19.42% and Penumbra (PEN) at 10.06% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
PEN
Health Care Equipment & Services industry group
10.06%
- Max
- 29.35%
- PEN
- 10.06%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
DexCom (DXCM) at 24.34% operates in the top operating margin quartile, ahead of Penumbra (PEN) at 12.37%, which runs around its industry’s norm.
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
PEN
Health Care Equipment & Services industry group
12.37%
- Max
- 35.43%
- Q3
- 14.14%
- PEN
- 12.37%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DXCM | PEN |
|---|---|---|
| ROE (TTM) | 37.67% | 10.67% |
| ROA (TTM) | 11.14% | 6.28% |
| Net Margin (TTM) | 19.42% | 10.06% |
| Operating Margin (TTM) | 24.34% | 12.37% |
| Gross Margin (TTM) | 63.42% | 67.99% |
Growth
Revenue Growth
Both DexCom (DXCM) at 15.60% and Penumbra (PEN) at 17.50% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Both companies show strong earnings momentum, but Penumbra (PEN) at 1,155.56% is the standout with EPS growth above its industry range; DexCom (DXCM) at 47.18% also sits in the top quartile.
Growth Metrics
| Metric | DXCM | PEN |
|---|---|---|
| Revenue Growth (YoY) | 15.60% | 17.50% |
| Revenue Growth (3Y CAGR) | 17.01% | 18.33% |
| EPS Growth (YoY) | 47.18% | 1,155.56% |
| EPS Growth (3Y CAGR) | 36.60% | -- |
Financial Strength
Current Ratio (MRQ)
DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Penumbra (PEN) at 5.89 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
PEN
Health Care Equipment & Services industry group
5.89
- Max
- 7.59
- PEN
- 5.89
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Penumbra (PEN) at 0.13 keeps leverage in the lower industry quartile, while DexCom (DXCM) at 0.55 runs a more typical debt-to-equity mix.
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
PEN
Health Care Equipment & Services industry group
0.13
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- PEN
- 0.13
- Min
- 0.00
Financial Strength Metrics
| Metric | DXCM | PEN |
|---|---|---|
| Current Ratio (MRQ) | 1.74 | 5.89 |
| Debt / Equity (MRQ) | 0.55 | 0.13 |
| Net Debt / EBITDA | -0.28 | -2.22 |
Dividends
Dividend Yield (TTM)
Neither DexCom (DXCM) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PEN
Health Care Equipment & Services industry group
0.00%
- PEN
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither DexCom (DXCM) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PEN
Health Care Equipment & Services industry group
0.00%
- PEN
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DXCM | PEN |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
DexCom (DXCM) at 31.26 is near its industry’s usual P/E ratio, while Penumbra (PEN) at 80.41 sits in the richer quartile — PEN needs stronger growth or earnings quality to justify the premium.
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
PEN
Health Care Equipment & Services industry group
80.41
- PEN
- 80.41
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Both DexCom (DXCM) at 5.80 and Penumbra (PEN) at 8.06 command a richer price per dollar of sales than most peers, sitting in the upper P/S ratio quartile of their industries.
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
PEN
Health Care Equipment & Services industry group
8.06
- Max
- 8.80
- PEN
- 8.06
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Both DexCom (DXCM) at 11.68 and Penumbra (PEN) at 7.95 carry a premium to book value versus peers, sitting in the upper P/B ratio quartile of their industries.
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
PEN
Health Care Equipment & Services industry group
7.95
- Max
- 11.68
- PEN
- 7.95
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DXCM | PEN |
|---|---|---|
| P/E Ratio (TTM) | 31.26 | 80.41 |
| P/S Ratio (TTM) | 5.80 | 8.06 |
| P/B Ratio (MRQ) | 11.68 | 7.95 |
| Free Cash Flow Yield (TTM) | 2.74% | 1.32% |